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Abstract
Background: In addition to forming the epithelial barrier against the outside environment keratinocytes are
immunologically active cells. In the treatment of severely burned skin, cryoconserved keratinocyte allografts gain in
importance. It has been proposed that these allografts accelerate wound healing also due to the expression of a favourable
- keratinocyte-derived - cytokine and growth factor milieu.
Methods: In this study the morphology and cytokine expression profile of keratinocytes from skin after acute burn injury
was compared to non-burned skin. Skin samples were obtained from patients after severe burn injury and healthy controls.
Cells were cultured and secretion of selected inflammatory mediators was quantified using Bioplex Immunoassays.
Immunohistochemistry was performed to analyse further functional and morphologic parameters.
Results: Histology revealed increased terminal differentiation of keratinocytes (CK10, CK11) in allografts from non-burned
skin compared to a higher portion of proliferative cells (CK5, vimentin) in acute burn injury. Increased levels of IL-1a, IL-2, IL-
4, IL-10, IFN-c and TNFa could be detected in culture media of burn injury skin cultures. Both culture groups contained large
amounts of IL-1RA. IL-6 and GM-CSF were increased during the first 15 days of culture of burned skin compared to control
skin. Levels of VEGF, FGF-basic, TGF-ß und G-CSF were high in both but not significantly different. Cryoconservation led to a
diminished mediator synthesis except for higher levels of intracellular IL-1a and IL-1ß.
Conclusion: Skin allografts from non-burned skin show a different secretion pattern of keratinocyte-derived cytokines and
inflammatory mediators compared to keratinocytes after burn injury. As these secreted molecules exert auto- and paracrine
effects and subsequently contribute to healing and barrier restoration after acute burn injury therapies affecting this specific
cytokine/growth factor micromilieu could be beneficial in burned patients.
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Introduction
Loss of the integrity of large portions of the skin as a result of
burn injury may lead to major disability or even death. As the skin
forms an active barrier protecting our organism from the outside
environment rapid restoration of the epidermal barrier is of vital
relevance after acute burn injury. Thus, appropriate wound care is
mandatory and various treatment modalities have been utilized to
improve and accelerate wound healing. In the past decades, the
increasing knowledge of the molecular and cellular mechanisms
underlying wound repair and regeneration has led to extensive
usage of growth factors in wound care [1–8]. Growth factors and
cytokines play major roles in the well-orchestrated integration of
the complex biological and molecular events underlying cutaneous
wound healing, including cell migration and proliferation,
extracellular matrix deposition, angiogenesis and tissue remodeling
[9]. However, the clinical effects of the topical application of single
growth factors to accelerate wound healing have been discourag-
ing: On the one hand due to the complexity of the wound healing
cascade and on the other due physical inhibition and biological
degradation of topically applied factors [10]. The development of
gene transfer technology promised to overcome the limitations
associated with the (topical) application of recombinant proteins by
delivering the respective growth factor directly to the wound bed
[11]. Also, stem cells - due to their pluripotency and their growth
potential - make them a potentially useful vehicle for gene delivery
to injury site [10]. Still, the use of stem cell technology is far from a
therapeutic application to date.
The epidermal skin barrier is formed by keratinocytes which
secrete a multitude of biological active molecules contributing
transiently to inflammatory responses and wound healing. In
particular, keratinocytes have been shown to control the behaviour
of fibroblasts during wound healing through the secretion,
activation or inhibition of cytokines and growth factors such as
TGF-b [12]. In the treatment of severely burned patients
autologous keratinocyte-sheets but also (cryoconserved) allografts
are used. It is supposed that in comparison to keratinocytes sheets
these allografts accelerate wound healing possibly due to the
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expression of favourable cytokines und growth factors. However,
the mechanisms of burn wound healing after allograft transplan-
tation are not well characterized.
Materials and Methods
Patients
Seventeen severely burned patients, admitted to the Depart-
ment of Burns, Community Hospital Bogenhausen, Munich,
Germany, between 2002 and 2005, were enrolled in this
prospective study. Inclusion criteria included: Admission within
24 hours post burn injury, burns covering more than 25% of the
total body surface area (TBSA), ,70 years of age, written consent
to the experimental protocol. The study design was approved by
the local ethics committee at the Ludwig-Maximilian University,
Munich, Germany. 17 randomly selected female patients who
underwent breast reduction surgery served as controls. On
admission, the extent and degree of burn was assessed and
recorded on a standard Lund and Browder chart. Information
recorded at the time of admission included burn related (date and
mechanism) as well as demographic data (age and gender). All
patients were treated in our burn intensive care unit according to
standardized protocols. Sepsis was defined as a positive blood
culture or pathologic tissue culture identifying the pathogen during
hospitalization or at autopsy, in combination with at least 3 of the
following: leucocytosis or leucopenia (.12,000 or ,4,000),
hyperthermia or hypothermia (.38.5 or ,36.5uC), tachycardia
(.150 BPM in children), refractory hypotension (systolic
BP,90 mmHg), thrombocytopenia (platelets ,50,000/mm3),
hyperglycemia (serum glucose .240 mg/dl), and enteral feeding
intolerance (residuals .200 cc/hr or diarrhea .1 L/day).
Isolation and culture of human keratinocytes
Tissue specimens were obtained during surgical debridement
close (approximately 5 cm) to full-thickness burn wounds. Tissue
from randomly selected female patients who underwent breast
reduction surgery served as a control. Epidermal keratinocytes
were isolated starting immediately after tissue harvest following the
method of Rheinwald and Green [13]. In brief, harvested tissue
was trypsinized (Trypsin 0,05%/EDT 0,02%, Gibco BRL,
Invitrogen GmbH, Karlsruhe, Germany) for 12 to 18 hours and
dermis was mechanically removed. Obtained cells were resus-
pended in Dulbecco’ s modified Eagle’ s medium (DMEM)/
HAMS-F-12 media (Biochrom AG Seromed, Berlin, Germany),
centrifuged at 200 g, resuspended in 20 ml of DMEM/HAMS-F-
12 media supplemented with L-Glutamine, NaHCO3, EGF, FCS,
gentamycin, insulin and hydrocortisone and seeded in cell culture
flasks at 26106 each flask. Culture medium was collected and
frozen in liquid nitrogen for further analysis after 72 hour
incubation periods prior to day 3, 10 and 15 (Figure 1). At day
15 confluent cells were washed with dispase solution (2,5 mg/ml
DMEM, Roche Diagnostics GmbH, Mannheim, Germany) for
20 minutes at 37 C and 5% CO2. A piece of Grassolind (Paul
Hartmann AG, Heidenheim, Germany) measuring 75 cm2 was
applied to the cell layer and attached by hemoclips. 24 hours later
the culture media was collected (pre cryo) before cell sheets were
frozen in MEM Earle supplemented with 20% FCS and 10%
DMSO at 280uC. Later on sheets were thawed and re-cultured in
DMEM. 24 hours thereafter culture media was collected and
frozen for further processing (post cryo, Figure 1).
Cellular morphology and immunhistochemistry
For routine light microscopy, cytospins from cultured keratino-
cytes from normal and burned skin were fixed in 10% formalin
and stained with hematoxylin and eosin (at day 10). Immunohis-
tochemistry was used to detect cytokeratin, vimentin and other
proteins in order to allow comparison of cellular composition in
allografts prepared from discarded tissue following breast reduc-
tion versus autologous cultured keratinocytes. For this, cytospins
were incubated with the respective primary monoclonal antibodies
(listed in Table 1). After frequent washings, a biotinylated rabbit
anti-rat secondary antibody or a rabbit anti-mouse secondary
antibody was applied respectively. After rinsing, enzyme conjugate
was applied for 10 min. Final incubation included Substrate–
Chromogen Mixture (3-amino- 9-ethylcarbazole, AEC) and
positive staining revealed a red precipitate.
Cytokine and growth factor measurements
The Bio-Plex Human Cytokine 17-Plex panel was used with the
Bio-Plex Suspension Array System (Bio-Rad, Hercules, CA) to
profile expression of interleukin (IL)-1a, IL-1 receptor antagonist
(IL-1Ra), IL-1b, IL-2, IL-4, IL-6, IL-10, interferon-gamma (IFN-
c), tumor necrosis factor alpha (TNF-a), Vascular endothelial
growth factor (VEGF), fibroblast growth factor basic (FGF-basic)
granulocyte colony-stimulating factor (GCSF) and granulocyte-
macrophage colony-stimulating factor (GM-CSF). The assay was
performed according to the manufacturer’s instructions. Briefly,
cell culture medium was centrifuged at 4500 rpm for 3 minutes at
4uC. Samples were then incubated with microbeads labeled with
specific antibodies to one of the aforementioned cytokines for
30 minutes. Following a washing step, the beads were incubated
with the detection antibody cocktail, each antibody specific to a
single cytokine. After another wash step, beads were incubated
with streptavidin-phycoerythrin for 10 minutes, again washed and
the concentration of each cytokine was determined using the array
reader. Transforming growth factor beta-1 (TGF-b1) was
determined by double-sandwich, enzyme-linked, immunosorbent
assays (Biosource Europe SA, B-1400 Nivelles, Belgium) according
to the protocol of the manufacturer in a microplate reader (Vmax,
Molecular Devices Corporation, Sunnyvale, CA, USA) at 450 nm.
Statistical analysis
Paired and unpaired Student’s t-test and Mann-Whitney tests
were used where appropriate. Data are expressed as means 6SD
or SEM as indicated. Differences were considered significant at a p
value of ,0.05.
Results
Patient characteristics
Characteristics of burn patients and controls at the time of
hospitalization are listed in Table 1. Patients were on average 41
years old and suffered from severe burn injury involving 42% of
TBSA and third-degree burn involving 28% of TBSA. There were
more male patients than female patients in the experimental
group. During acute hospitalization, 24% of the patients suffered
from inhalation injury, sepsis occurred in 29% and multi-organ
failure (MOV) in 18% of patients. 24% of our patients
subsequently died from their injuries (Table 2). 17 randomly
selected female patients aged 20 to 50 years (mean 3767 years)
who underwent breast reduction surgery served as controls.
H&E stainings and immunhistochemistry
H&E stainings revealed a significantly increased proportion of
terminally differentiated cells (white arrows) in allogenic cultured
epithelial grafts from control tissue (Fig. 2A) in comparison to cells
from autologous cultured epithelial grafts from burn patients
(Fig. 2B). In stainings with the monoclonal antibody KL-1 (which
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marks the cytokeratins 2, 6, 8, 10, 11, 18 and 19 and especially K
6, 10 and 11 are expressed by terminally differentiated
keratinocytes) significantly more terminal differentiated keratino-
cytes in allogenic graft (Fig. 2C) were detected compared with
autologous cultured epithelial grafts (Fig. 2D). Vimentin is
expressed by mesenchymal cells (e.g. fibroblasts) but also by
basaloid keratinocytes. More vimentin-positive cells were present
in autologous cultured epithelial grafts (Fig. 2F) when compared to
allogenic sheets (Fig. 2E). No CD-209, 1F11 or T-200 (CD45) or
MOPC-21 expressing cells could be detected in either group
indicating the absence of dermal dendritic cells, macrophages,
monocytes, endothelial cells and leukocytes (data not shown).
Cytokine expression profiles
No significant differences between groups could be measured in
culture supernatants for IL-1a within the first 15 days of culture
(Fig. 3A). During cell culture, levels of IL-1b were barely
detectable at all time points measured (Fig. 3B). In contrast, IL-
1RA was detected at high concentrations in culture media of both
patients and controls peaking at day 15 (16690,6962258,85 pg/
ml vs. 12807,6863016,70, respectively) without revealing any
significant difference between patients and controls (Fig. 3C).
Analyses of keratinocyte culture media revealed significantly
elevated levels of IL-2, -4, -6, -10, IFN-c, TNF-a and GM-CSF
(Fig. 3D–I, N) at most of the first three time points studied in the
patient group compared to control patients. However, expression
of most of the respective cytokines was generally very low.
Expression levels of these cytokines did not significantly differ
when comparing non-surviving patients with survivors of the burn
trauma (data not shown).
IL-6 and GM-CSF were significantly increased during the first
15 days of culture after acute burn injury compared to control skin
(Fig. 3F, N) as a result of significant higher expression in non-
survivors, Fig. 3O, P). Concentrations of IL-6 increased early after
burn injury peaking at 10 days post injury (2874,0461352,89 pg/
ml) while culture media analysis of the control group demonstrated
basic levels during the 15 day culture period (with
69,35621,82 pg/ml; 60,37628,19 pg/ml, and 98,28635,38 pg/
ml, respectively). Noteworthy, when differentiating between
survivors and non-survivors, keratinocytes of patients that did
not survive the burn trauma revealed significantly increased
secretion of IL-6 at the first three time points measured when
compared to the survivor group. The expression profile of GM-
CSF revealed a similar pattern however, differences between
groups were, although statistically significant, not as pronounced
as with IL-6.
Levels of VEGF, TGF-ß, FGF-basic und G-CSF could be
detected at relatively high concentrations, however only moderate
differences could be detected comparing the two collectives
(Fig. 3J–M). Interestingly, at 3 and 10 days post burn,
keratinocytes isolated close to a burn wound did secrete
significantly elevated levels of TGF-b1 compared to normal
controls (e.g. 526,43661,16 pg/ml and 362,59638,50 pg/ml at
day 10, respectively). No differences could be detected comparing
the secretion profile of keratinocytes from patients that did not
survive the thermal trauma when compared to surviving patients.
When grafts of keratinocytes were prepared after 15 days and
then frozen a diminished mediator synthesis from grafts from burn
patients and controls after a freeze/thaw cycle was measured. In
contrast, significant higher levels of IL-1a, IL-1ß, IL-1RA were
observed in cultured keratinocytes from burn injury patients after
a freeze/thaw cycle and further culture for 24 hours as compared
to control keratinocytes (Fig. 3A–C).
Discussion
Tissue-engineered skin substitutes constitute a promising
alternative for the permanent closure of burn wounds and in the
meantime protocols have been established for the culture of large
numbers of human epidermal keratinocytes [3,14]. In particular,
Figure 1. Time line and study design.
doi:10.1371/journal.pone.0029942.g001
Table 1. Antibodies used for immunohistochemical analyses.
Antigen Anti- Isotype Product # Company conc.
Control MOPC21 IgG1 M9269 Sigma 1 mg/ml
Control UPC-10 IgG2a M9144 Sigma 1 mg/ml
Cytokeratin 2,6,8,10,11,18,19 Kl-1 IgG1 1918 Immunotech, Marseille 126,5 ng/ml
Vimentin Vim 3B4 IgG2a M7020 Sigma 60 mg/ml
CD 45 T 200 IgG1 M0701 Sigma 0,45 mg/ml
PECAM-1/CD 31 1F11 IgG1 2052 Klon 1F11 Immunotech, Marseille 200 ng/ml
DC-Sign/ CD 209 DCN46 IgG2b 551249 BD Biosciences 31,25 mg/ml
doi:10.1371/journal.pone.0029942.t001
Keratinocytes and Burn Injury
PLoS ONE | www.plosone.org 3 February 2012 | Volume 7 | Issue 2 | e29942
autologous epithelial cells grown from a single full-thickness skin
biopsy have been available for nearly three decades [15]. These
keratinocytes were considered solely as reconstituting elements of
the skin barrier. Meanwhile it is well known that these cells secrete
a multitude of biological relevant molecules which contribute to
inflammatory and immunological responses and wound healing
[12]. Particularly, release of IL-1 from various cells at the wound
site seems to represent the initial trigger for the inflammatory
reaction and serves as an autocrine, activating signal to fibroblasts
and endothelial cells [16,17].
The characterization of the secreted factors from keratinocytes
could improve our understanding of their role in wound healing
and – in the case of skin graft transplantation for burn injuries –
improve treatments. When comparing the cellular morphology of
keratinocytes in allografts made of breast reductions with
autologous keratinocytes from burns removed close to the wound
we observed differences in proliferative activity and differentiation
as indicated by increased expression of vimentin in autologous
cultured epithelial grafts and elevated KL-1 expression by
keratinocytes isolated from breast reduction tissue.
Comparing the in vitro cytokine secretion profile of keratinocytes
obtained from an area close to a full-thickness burn wound after
longterm culture with normal keratinocytes significantly elevated
levels of IL-2, -4, -6, -10, IFN-c, TNF-a, TGF-b1 and GM-CSF in
culture media of keratinocytes from burn patients were observed.
In contrast, only minimal concentrations of IL-1b and no
significant differences in IL-1a expression could be detected.
While keratinocytes express the inactive pro-IL-1b, its active form
is secreted [18]. Still, IL-1b was barely detectable in our
experiments. IL-1a on the other hand, is barely detectable under
physiologic conditions, but may be secreted by keratinocytes after
tissue damage [18]. In our analyses IL-1a was detected in cultures
from burn patients and controls, however no significant difference
was observed after 15 days of culture.
IL-6, TNF-a, and TGF-b1 are further mediators known to exert
pro-inflammatory (IL-6, TNF-a [19,20]) and keratinocyte and
fibroblast proliferating (IL-6 [21], TNF-a [22,23], and TGF-b
[24]) properties and may thus significantly contribute to the
physiologic wound healing process. Keratinocytes in healthy skin
do rarely express IL-6 [25]. However, cutaneous injury or
physiological processes such as UVB irradiation induce increased
IL-6 expression in different cell types of the dermis and in
keratinocytes [26]. The significantly enhanced in vitro release of the
potent mitogen and pro-inflammatory cytokine IL-6 from
keratinocytes after severe burns may thus be important in the
inflammatory event and the increased activity of the thermally
affected epithelial cells with auto- and paracrine effects.
In addition, genes and proteins of IL-6 and GM-CSF show a
high sequence homology and their receptor binding and signal
transduction structures are uniform. This suggests common signal
transduction and activation pathways [26] and may explain their
comparable expression profiles in our study. Indeed, increased
GM-CSF expression in human and murine skin with damaged
barrier function has been demonstrated in various studies [27–29].
TNF-a is predominantly expressed in keratinocytes and has a
profound autocrine effect on keratinocytes in wound healing.
Expression of this growth factor is upregulated in keratinocytes
after skin injury [30]. Surprisingly, wound healing experiments in
TNF-a -deficient mice showed no abnormal wound healing
phenotype [31,32]. TNF-a acts as strong mitogen for fibroblasts
[33]. However, the lack of an obvious mesenchymal phenotype in
TNF-a-deficient mice suggests that this growth factor is dispens-
able for fibroblast proliferation and that its loss can be
compensated by other EGFR ligands.
TGF-b plays an important role in wound healing as
demonstrated in various in vitro and in vivo studies. The TGF-b
family consists of at least five highly conserved polypeptides, with
TGF-b1, -2 and -3 being the principal mammalian forms. TGF-b1
and -2 are one of the most important stimulators of collagen and
proteoglycan synthesis, and affect the ECM not only by
stimulating collagen synthesis but also by preventing its breakdown
Table 2. Patient characteristics (n = 17).
Patient characteristics Mean 6 SEM
Age (years) 4164
Gender (F/M) 3/14
TBSA (%) 4262
3rd degree (%) 2864
MOV (%) 18
Inhalation injury (%) 24
Sepsis (%) 29
Non-survivors (%) 24
Randomly selected female patients who underwent breast reduction surgery
served as a control population (n = 17; Age 3767 years).
doi:10.1371/journal.pone.0029942.t002
Figure 2. Morphological characterization of keratinocytes from
acute burn injury. H&E stainings revealed a significantly increased
proportion of terminally differentiated cells (white arrows) in allogenic
cultured epithelial grafts (Fig. 2A) from breast reduction material in
comparison to cells from autologous cultured epithelial grafts from
burn patients (Fig. 2B). In stainings with the monoclonal antibody KL-1
significantly more terminal differentiated keratinocytes in allogenic
grafts (Fig. 2C) were detected compared with autologous cultured
epithelial grafts (Fig. 2D). More vimentin-positive cells are present in
autologous cultured epithelial grafts (Fig. 2F) when compared to
allogenic sheets (black arrows, Fig. 2E).
doi:10.1371/journal.pone.0029942.g002
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[34,35]. In contrast, TGF-b3, which is predominantly induced in
the later stages of wound healing, has been found to reduce
connective tissue deposition [36]. Hence, overexpression of TGF-
b1 and b2 has been linked to excessive scar formation [37,38],
while increased levels of TGF-b3 appear to prevent excessive scar
formation. Specifically, beyond one-week, differential expression
of TGF-b isoforms, receptors and activity modulators, rather than
the mere presence or absence of TGF-b, may have a major role in
the development of keloids and hypertrophic scarring [39].
Although, within this study only TGF-b1 was quantified, its
significantly increased secretion by keratinocytes obtained from
burn wounds may indeed stimulate underlying fibroblasts to
produce elevated levels of ECM and by this significantly
contributing to hypertrophic scar formation, commonly observed
this patient population.
Noteworthy, VEGF, FGF-basic, and G-CSF were produced in
relatively high quantities with no significant differences between
groups. VEGF represents one of the most important pro-
angiogenic factors. It accelerates wound healing by increasing
neovascularization during the early period of wound healing
[10,40]. FGF-basic is produced by keratinocytes and has
chemotactic effects on fibroblasts, smooth muscle cells, endothelial
cells and keratinocytes [41]. Like VEGF it has pro-angiogenic
properties and is essential for wound healing [42]. Clinically, local
application of FGF-basic led to improved healing of diabetic ulcers
[43].
However, the application of cultured keratinocytes no matter if
autologous or allogenic requires the presence of a dermal
component since keratinocytes do not stimulate granulation tissue
formation or dermal remodelling in full-thickness wounds [44,45].
Therefore, autologous or allogenic keratinocyte sheets are less
suited for application onto inert, poorly granulating wounds (e.g.,
ulcers). They are more suited for the application onto well-
granulating wounds in which the dermal component is already
present. E.g. cultured keratinocyte sheets are applied onto large
burns in a two-step procedure in which a dermal compartment
(dead donor dermis) is initially applied and allowed to stabilize
(develop capillaries) before applying the cultured keratinocytes
[46]. Based on the delay between taking a biopsy specimen from
the patient and the keratinocyte autograft becoming available,
sheets of allogenic origin from unrelated donors have been used as
keratinocyte allografts. Their proposed mechanisms of actions of
on wound healing may indeed be mostly exerted via the secretion
of the respective growth factors. However, in our study, freezing
led to a diminished mediator synthesis, except for significant
higher levels of IL-1a and IL-1ß, probably as a result of physical
cell destruction after thawing. It thus remains questionable if
cytokines and growth factors of interest survive deep-freezing.
In conclusion, epidermal keratinocytes from burn patients show
an increased proliferative activity with augmented mediator
release compared to keratinocytes isolated from control donors.
In the future, the substitution of cellular growth-enhancing
cytokines and mediators (and maybe additional cell types besides
keratinocytes) in the bioengineered skin substitutes may prove
promising to generate skin grafts with improved wound-healing
function after burn injury.
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